Patents by Inventor Katherine S. Panageas

Katherine S. Panageas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PERIPHERAL BLOOD PHENOTYPE LINKED TO OUTCOMES AFTER IMMUNOTHERAPY TREATMENT
    Publication number: 20240085417
    Abstract: Provided are methods of assigning a LAG+, LAG?, or PRO immunotype to a cancer patient based on the frequencies of LAG-3+CD8+T-cells, Ki67+CD8+T-cells, Tim-3+CD8+T-cells, and ICOS+CD8+T-cells in a peripheral blood sample from the patient, and selecting an anti-cancer therapy, for example, an immune checkpoint blockade (ICB) therapy, based on the patient's immunotype.
    Type: Application
    Filed: January 20, 2022
    Publication date: March 14, 2024
    Inventors: Margaret K. Callahan, Arshi Arora, Taha Merghoub, Katherine S. Panageas, Michael A. Postow, Ronglai Shen, Jedd D. Wolchok